PEDIATRIC LATE OUTCOMES PROTOCOL ACTG 219C

儿科晚期结果方案 ACTG 219C

基本信息

  • 批准号:
    7607845
  • 负责人:
  • 金额:
    $ 11.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-03-23 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219c The purpose of this study is to follow all infants, childern and adolescents who are seen at Pediatric AIDS Clinical Trials Group sites as well as infants born to HIV-infected mothers who were enrolled in a PACTG drug study when they were pregnant, to look for long-term benefits or any late, harmful effects of medications or vaccines taken. All childern are eligible to be followed until at least their 24th birthday.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon A Nachman其他文献

Preliminary Evaluation of Nelfinavir (NFV) Pharmacodynamics in Stable Antiretroviral Experienced HIV-Infected Children Following Initiation of HAART (PACTG 377)
  • DOI:
    10.1203/00006450-199904020-00974
  • 发表时间:
    1999-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    George M Johnson;Kenneth Stanley;Andrew Wiznia;Paul Krogstad;Sophia Lee;Francesca Aweeka;Sandra Hayashi;Sharon A Nachman
  • 通讯作者:
    Sharon A Nachman

Sharon A Nachman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon A Nachman', 18)}}的其他基金

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US
LOC-IMPAACT 领导小组瑞德西韦治疗美国孕妇 COVID-19 的药代动力学和安全性
  • 批准号:
    10174121
  • 财政年份:
    2020
  • 资助金额:
    $ 11.14万
  • 项目类别:
SURVEILLANCE MONITORING FOR ART TOXICITIES
艺术毒性的监测
  • 批准号:
    7950826
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: PHASE I/II STUDY OF SAFETY AND IMMUNOGENICITY OF QUADRIVALENT ME
临床试验:四价 ME 安全性和免疫原性的 I/II 期研究
  • 批准号:
    7950829
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF
临床试验:I/II 期多中心、开放标签、HIV AF 非比较研究
  • 批准号:
    7950832
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: PSYCHIATRIC CO-MORBIDITY IN PERINATALLY HIV-INFECTED CHILDREN AN
临床试验:围产期 HIV 感染儿童的精神共病
  • 批准号:
    7950791
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH
临床试验:患有以下疾病的婴儿/儿童的神经发育/神经学研究
  • 批准号:
    7950780
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: REGIMENS/TREATMENT SWITCHING STRATEGIES IN HIV CHILDREN ACTG390
临床试验:艾滋病毒儿童的治疗方案/治疗转换策略 ACTG390
  • 批准号:
    7950782
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLINICAL TRIAL: PHASE II SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN P
临床试验:四价人 P 的 II 期安全性和免疫原性研究
  • 批准号:
    7950822
  • 财政年份:
    2008
  • 资助金额:
    $ 11.14万
  • 项目类别:
IMMUNOLOGIC MEMORY FOLLOWING PNEUMOCOCCAL, HEP B, AND MEASLES VACCINATION P1061
肺炎球菌、乙型肝炎和麻疹疫苗接种后的免疫记忆 P1061
  • 批准号:
    7607895
  • 财政年份:
    2007
  • 资助金额:
    $ 11.14万
  • 项目类别:
A DUAL PI-BASED HAART REGIMEN VS A MULTI-NRTI ART REGIMEN, PACTG P1053
基于双 PI 的 HAART 方案与多 NRTI ART 方案,PACTG P1053
  • 批准号:
    7607899
  • 财政年份:
    2007
  • 资助金额:
    $ 11.14万
  • 项目类别:

相似海外基金

Childhood socioeconomic disadvantage, cumulative Adverse Childhood Experiences, and adolescent depression and anxiety symptoms
童年社会经济劣势、累积的不良童年经历以及青少年抑郁和焦虑症状
  • 批准号:
    10676396
  • 财政年份:
    2023
  • 资助金额:
    $ 11.14万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Impact of Longitudinal Patterns of Adverse Childhood Experiences on Adolescent Reproductive Health: Examining Factors that Promote Resilience
不良童年经历的纵向模式对青少年生殖健康的影响:检查促进复原力的因素
  • 批准号:
    10722456
  • 财政年份:
    2023
  • 资助金额:
    $ 11.14万
  • 项目类别:
International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY)
儿童、青少年和年轻成人癌症幸存者后续结直肠癌的国际研究 (I-SCRY)
  • 批准号:
    10569105
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
Seventh International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma
第七届儿童、青少年和青年非霍奇金淋巴瘤国际研讨会
  • 批准号:
    10539036
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
  • 批准号:
    10459788
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
OPTIMISE: Optimal precision therapies to customise care in childhood and adolescent cancer
OPTIMISE:最佳精准疗法,定制儿童和青少年癌症护理
  • 批准号:
    465500
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Operating Grants
International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY)
儿童、青少年和年轻成人癌症幸存者后续结直肠癌的国际研究 (I-SCRY)
  • 批准号:
    10375018
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
  • 批准号:
    10675772
  • 财政年份:
    2022
  • 资助金额:
    $ 11.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了